Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS – OPERATING ACTIVITIES    
Net loss $ (13,696) $ (12,856)
Adjustments required to reconcile cash flows used in operating activities:    
Depreciation 528 560
Stock-based compensation 1,355 254
Finance expense (income), net 247 (506)
Revaluation of contingent consideration 3 (2)
Income from change in fair value of warrants (2,412) (3,858)
Private Placement Warrants issuance cost 732
Change in contract liability (1,976)
Loss from sale and disposal of property and equipment, net 165 97
Changes in operating assets and liabilities:    
Other current assets 1,096 803
Trade accounts payable 294 (2,229)
Other accounts payable (2,404) (2,921)
Net change in operating leases 3 (691)
Net cash used in operating activities (14,821) (22,593)
CASH FLOWS – INVESTING ACTIVITIES    
Cash and restricted cash acquired from the APT acquisition 663
Proceeds from sale of property and equipment 109 63
Purchases of property and equipment (9)
Net cash provided by investing activities 109 717
CASH FLOWS – FINANCING ACTIVITIES    
Issuance of Common Stock under February 2025 SPA 996
February 2025 SPA issuance costs (118)
Issuance of Common Warrants under February 2025 SPA 4,531
Issuance of Common Stock under Inducement Letter Agreements 6,473
Issuance of Private Placement Warrants under March 2024 PIPE 28,745
Issuance of Redeemable Convertible Preferred Shares under March 2024 PIPE 21,269
March 2024 PIPE issuance costs (507)
Pre-Funded Warrants and Common Warrants exercise 2 6
Issuance of Common Stock under Open Market Sales Agreement, net of issuance costs 19
Issuance cost from the APT acquisition (13)
Repayment of long-term debt (10,747)
Net cash provided by financing activities 11,884 38,772
Increase (decrease) in cash and cash equivalents and restricted cash (2,828) 16,896
Effect of exchange rate changes on cash and cash equivalents and restricted cash 39 (46)
Cash and cash equivalents and restricted cash at the beginning of the period 17,975 15,864
Cash and cash equivalents and restricted cash at the end of the period 15,186 32,714
RECONCILIATION OF AMOUNTS ON CONSOLIDATED BALANCE SHEETS    
Cash and cash equivalents 14,046 31,611
Restricted cash 1,140 1,103
Total cash and cash equivalents and restricted cash 15,186 32,714
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid for interest 10 1,419
Taxes paid 3 7
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Property and equipment purchases included in other accounts payable and trade accounts payable 2 10
March 2024 PIPE issuance cost 1,685
Issuance cost from the APT acquisition 38
Issuance of Common Stock under the APT acquisition 3,041
Issuance of Redeemable Convertible Preferred Shares under the APT acquisition 12,610
Issuance of Merger Warrants under the APT acquisition $ 200